0001237899-12-000087.txt : 20121127
0001237899-12-000087.hdr.sgml : 20121127
20121127175403
ACCESSION NUMBER: 0001237899-12-000087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121126
FILED AS OF DATE: 20121127
DATE AS OF CHANGE: 20121127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAKER CHARLES A
CENTRAL INDEX KEY: 0001225470
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 121227377
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2012-11-26
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001225470
BAKER CHARLES A
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2012-11-26
4
M
0
1100.0
9.17
A
10690.0
D
Common Stock
2012-11-26
4
S
0
1100.0
175.14
D
9590.0
D
Common Stock
2012-11-26
4
M
0
6565.0
9.17
A
16155.0
D
Common Stock
2012-11-26
4
S
0
6565.0
174.46
D
9590.0
D
Common Stock
2012-11-26
4
M
0
5035.0
9.17
A
14625.0
D
Common Stock
2012-11-26
4
S
0
5035.0
173.63
D
9590.0
D
Common Stock
2012-11-26
4
M
0
1200.0
9.17
A
10790.0
D
Common Stock
2012-11-26
4
S
0
1200.0
172.65
D
9590.0
D
Common Stock
2012-11-26
4
M
0
1100.0
9.17
A
10690.0
D
Common Stock
2012-11-26
4
S
0
1100.0
171.45
D
9590.0
D
Non-Qualified Stock Option (right to buy)
9.17
2012-11-26
4
M
0
1100.0
D
2015-01-03
Common Stock
1100.0
13900.0
D
Non-Qualified Stock Option (right to buy)
9.17
2012-11-26
4
M
0
6565.0
D
2015-01-03
Common Stock
6565.0
7335.0
D
Non-Qualified Stock Option (right to buy)
9.17
2012-11-26
4
M
0
5035.0
D
2015-01-03
Common Stock
5035.0
2300.0
D
Non-Qualified Stock Option (right to buy)
9.17
2012-11-26
4
M
0
1200.0
D
2015-01-03
Common Stock
1200.0
1100.0
D
Non-Qualified Stock Option (right to buy)
9.17
2012-11-26
4
M
0
1100.0
D
2015-01-03
Common Stock
1100.0
0.0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 26, 2012 at prices ranging from $175.00 to $175.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
Represents volume-weighted average price of sales of 6,565 shares of Company stock on November 26, 2012 at prices ranging from $174.07 to $174.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
Represents volume-weighted average price of sales of 5,035 shares of Company stock on November 26, 2012 at prices ranging from $173.08 to $173.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
Represents volume-weighted average price of sales of 1,200 shares of Company stock on November 26, 2012 at prices ranging from $172.06 to $172.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 26, 2012 at prices ranging from $171.01 to $171.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Charles A. Baker
2012-11-27